WO1999021437A1 - Additif alcalin - Google Patents
Additif alcalin Download PDFInfo
- Publication number
- WO1999021437A1 WO1999021437A1 PCT/US1998/022422 US9822422W WO9921437A1 WO 1999021437 A1 WO1999021437 A1 WO 1999021437A1 US 9822422 W US9822422 W US 9822422W WO 9921437 A1 WO9921437 A1 WO 9921437A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- additive
- invention defined
- alkaline
- amino acids
- sodium
- Prior art date
Links
- 239000000654 additive Substances 0.000 title claims abstract description 21
- 230000000996 additive effect Effects 0.000 title claims abstract description 20
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical class [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims abstract description 20
- 239000011573 trace mineral Substances 0.000 claims abstract description 14
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 14
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 13
- 150000001413 amino acids Chemical class 0.000 claims abstract description 13
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims abstract description 12
- 239000011734 sodium Substances 0.000 claims abstract description 12
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 12
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 8
- 229910001629 magnesium chloride Inorganic materials 0.000 claims abstract description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000011777 magnesium Substances 0.000 claims abstract description 5
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 5
- 239000011701 zinc Substances 0.000 claims abstract description 5
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000011575 calcium Substances 0.000 claims abstract description 4
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 4
- 229910000404 tripotassium phosphate Inorganic materials 0.000 claims description 8
- 235000019798 tripotassium phosphate Nutrition 0.000 claims description 8
- 108010010803 Gelatin Proteins 0.000 claims description 4
- 229920000159 gelatin Polymers 0.000 claims description 4
- 239000008273 gelatin Substances 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims description 4
- 108010028690 Fish Proteins Proteins 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 abstract description 10
- 235000013361 beverage Nutrition 0.000 abstract description 9
- 239000002775 capsule Substances 0.000 abstract description 8
- 235000002639 sodium chloride Nutrition 0.000 abstract description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract description 3
- 235000015218 chewing gum Nutrition 0.000 abstract description 3
- 239000011780 sodium chloride Substances 0.000 abstract description 3
- 235000012206 bottled water Nutrition 0.000 abstract description 2
- 241001122767 Theaceae Species 0.000 abstract 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 14
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- 239000003792 electrolyte Substances 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 235000013616 tea Nutrition 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000003651 drinking water Substances 0.000 description 5
- 235000020188 drinking water Nutrition 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229960003975 potassium Drugs 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 159000000001 potassium salts Chemical class 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000019832 sodium triphosphate Nutrition 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 244000005894 Albizia lebbeck Species 0.000 description 1
- 241000779745 Backhousia myrtifolia Species 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000293 acute skin toxicity Toxicity 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 229940085468 ascorbic acid 400 mg Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000005800 cardiovascular problem Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 230000007684 eye toxicity Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 231100000327 ocular toxicity Toxicity 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- HWGNBUXHKFFFIH-UHFFFAOYSA-I pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O HWGNBUXHKFFFIH-UHFFFAOYSA-I 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- PHZLMBHDXVLRIX-UHFFFAOYSA-M potassium lactate Chemical compound [K+].CC(O)C([O-])=O PHZLMBHDXVLRIX-UHFFFAOYSA-M 0.000 description 1
- 239000001521 potassium lactate Substances 0.000 description 1
- 235000011085 potassium lactate Nutrition 0.000 description 1
- 229960001304 potassium lactate Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-I triphosphate(5-) Chemical compound [O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O UNXRWKVEANCORM-UHFFFAOYSA-I 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
Definitions
- U.S. Patent No. 4,592,892 to Ueno, et al relates to an aqueous food sterilizing agent utilizing in part an alkaline carbonate that may be potassium carbonate.
- the U.S. Patent No. 4,851 ,242, Dubois, et al. describes a nutritional product for animals consisting of aggregates of organic sea limestones of recent formation, part of which is tripotassium phosphate.
- An object of the invention is a low sodium additive for alkaline dietary supplement dosages that is mild in terms of acute and sub acute skin and eye toxicity, yet still capable of producing beverages with pH above 9.
- Still another object is such an additive that offers up to 79 additional trace minerals including calcium, zinc and magnesium.
- a fish protein is mixed into the hot water with the propeller mixer set at about 300 to 600 r.p.m.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicinal Preparation (AREA)
Abstract
Selon l'invention, on peut utiliser, en tant qu'additif, une solution très alcaline et à très faible teneur en sodium de phosphate de tripotassium saturé, dans des présentations comme des gouttes concentrées, des comprimés, des gélules, des boissons, des sachets de thé ou d'autres formes de présentation. Cet additif comprend en outre du calcium, du zinc, du magnésium et jusqu'à 79 oligo-éléments provenant de sel marin. Ces oligo-éléments sont chélatés à l'aide d'acides aminés et pris à partir de dépôts marins de chlorure de magnésium, à faible teneur en sodium. Les acides aminés proviennent d'une source non porcine. L'additif, qui est considéré sur le plan nutritionnel comme ayant une teneur nulle en sodium, peut être utilisé sous forme de gouttes aqueuses concentrées, ou sous forme sèche, en tant qu'additif de formulations destinées à un complément diététique, notamment des comprimés, gélules, gommes à mâcher, sachets de thé, eau embouteillée, boissons et autres.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95912197A | 1997-10-28 | 1997-10-28 | |
| US08/959,121 | 1997-10-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1999021437A1 true WO1999021437A1 (fr) | 1999-05-06 |
Family
ID=25501693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1998/022422 WO1999021437A1 (fr) | 1997-10-28 | 1998-10-23 | Additif alcalin |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO1999021437A1 (fr) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7597909B2 (en) * | 1999-11-06 | 2009-10-06 | Janmarie Hornack | Dietary supplement containing alkaline electrolyte buffers |
| US9357797B2 (en) | 1999-11-06 | 2016-06-07 | Janmarie Hornack | Dietary supplement containing alkaline electrolyte buffers |
| US11926541B2 (en) | 2015-05-15 | 2024-03-12 | G Water Llc | Process of making alkaline and acidic water |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3215626A (en) * | 1963-01-08 | 1965-11-02 | Sparkletts Drinking Water Corp | Process of producing mineralized drinking water |
| US5292538A (en) * | 1992-07-22 | 1994-03-08 | Metagenics, Inc. | Improved sustained energy and anabolic composition and method of making |
| US5294606A (en) * | 1992-11-24 | 1994-03-15 | Reliv' International Inc. | Isotonic energy composition and method to use same |
| US5296246A (en) * | 1991-08-08 | 1994-03-22 | Fujix Corporation | Active amino acid Ca, beverages containing same, and process for their production |
| US5424074A (en) * | 1989-06-20 | 1995-06-13 | Otsuka Pharmaceutical Co., Ltd. | Pharmaceutical composition for potassium supplementation |
-
1998
- 1998-10-23 WO PCT/US1998/022422 patent/WO1999021437A1/fr active Application Filing
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3215626A (en) * | 1963-01-08 | 1965-11-02 | Sparkletts Drinking Water Corp | Process of producing mineralized drinking water |
| US5424074A (en) * | 1989-06-20 | 1995-06-13 | Otsuka Pharmaceutical Co., Ltd. | Pharmaceutical composition for potassium supplementation |
| US5296246A (en) * | 1991-08-08 | 1994-03-22 | Fujix Corporation | Active amino acid Ca, beverages containing same, and process for their production |
| US5292538A (en) * | 1992-07-22 | 1994-03-08 | Metagenics, Inc. | Improved sustained energy and anabolic composition and method of making |
| US5294606A (en) * | 1992-11-24 | 1994-03-15 | Reliv' International Inc. | Isotonic energy composition and method to use same |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7597909B2 (en) * | 1999-11-06 | 2009-10-06 | Janmarie Hornack | Dietary supplement containing alkaline electrolyte buffers |
| US8298588B2 (en) * | 1999-11-06 | 2012-10-30 | Janmarie Hornack | Dietary supplement containing alkaline electrolyte buffers |
| US8557299B2 (en) | 1999-11-06 | 2013-10-15 | Janmarie Hornack | Dietary supplement containing alkaline electrolyte butters |
| US9357797B2 (en) | 1999-11-06 | 2016-06-07 | Janmarie Hornack | Dietary supplement containing alkaline electrolyte buffers |
| US9808441B2 (en) | 1999-11-06 | 2017-11-07 | Janmarie Hornack | Dietary supplement containing alkaline electrolyte buffers |
| US11926541B2 (en) | 2015-05-15 | 2024-03-12 | G Water Llc | Process of making alkaline and acidic water |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3213666B2 (ja) | クレアチン飲料の製造方法 | |
| JPH0789852A (ja) | 高濃度のカルシウムを含有する水溶性粉末およびその 製造方法 | |
| JP2808166B2 (ja) | 鉄強化飲料の製造方法 | |
| US20040013784A1 (en) | Additive method of standardized drinks and potable water production | |
| US20130122150A1 (en) | Alkaline Antioxidant Mineral Water | |
| US6740502B2 (en) | Method for preparing zinc-oligopeptide easily absorbable by the human body | |
| WO1999021437A1 (fr) | Additif alcalin | |
| TWI377914B (fr) | ||
| US20040009235A1 (en) | Nanometer grade hydroxyapatite composition for replenishing calcium | |
| WO2007090504A1 (fr) | Collagene hydrolyse et ses utilisations | |
| US20120207883A1 (en) | Alkaline booster with antioxidants | |
| JP2007070316A (ja) | 経口用組成物及び栄養補助食品 | |
| RU2667781C1 (ru) | Биологически активная добавка из кедровой скорлупы и способ ее получения | |
| US20130122140A1 (en) | Alkaline Mineral Booster With Antioxidants | |
| JP2005058017A (ja) | リン脂質含有組成物 | |
| CN101322559B (zh) | 多功能高效补钙剂 | |
| CN107439866A (zh) | 枸杞鹰嘴豆植物营养素饮料及其制备工艺 | |
| JPH0898647A (ja) | 金属結合カゼインを配合した栄養組成物 | |
| CN113749203A (zh) | 一种具有减肥作用的饮品及制备方法 | |
| JP2002142723A (ja) | ダイエット加工食品用原料およびダイエット加工食品 | |
| KR19990015781A (ko) | 미역추출물을 주성분으로 하는 미역음료의 제조방법 | |
| JPH09154534A (ja) | 茶の葉とにんにくの粉末を主成分とした滋養食、飲料及 びその製造方法 | |
| CN109198339A (zh) | 一种南极磷虾油饮品 | |
| JP2004024181A (ja) | 栄養補給食品 | |
| RU2217141C1 (ru) | Состав "витализин-1" для профилактики атеросклероза, сердечно-сосудистых заболеваний и поддерживающей терапии вирусных заболеваний |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): CN JP KR |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| 122 | Ep: pct application non-entry in european phase |